AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05879224 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Revised case management package
Description: 1. Point-of-care quantitative G6PD testing using G6PDSTANDARD (SD Biosensor) prior to use of primaquine (Day 0)~2. Prescription of short course primaquine (7 mg/kg total)(Day 0):~   * PQ7 (1 mg/kg/day for 7 days) if G6PD activity greater than 70 percent~  * PQ14 (0.5 mg/kg/day for 14 days) if G6PDactivity is 30-70 percent~  * PQ8w (0.75 mg/kg/week for 8 weeks) if G6DPactivity less than 30 percent~3. Participant counselling at the health facility (Day 0):~   * Supervision of first dose of primaquine~  * Education regarding the importance and risks of primaquine therapy and necessity to take primaquine with food~4. Community based clinical review on Day 3 (and Day 7 for the first 300 participants) to detect and manage gastrointestinal or haemolytic adverse effects of treatment and encourage adherence to full treatment regime~5. Improved malariometric surveillance and pharmacovigilance to support wider scale use of the revised case management
Study NCT05837702 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ESPB
Description: Erector spinae plane block
Study NCT05837702 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PVB
Description: Paravertebral Block
Study NCT05837702 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CONTROL
Description: No block has been done
Study NCT05400252 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Omnis Salutis
Description: Omnis Salutis is a Veteran-targeted, Whole Health program for mental health care settings and teaches Veterans the skills to identify and communicate their Whole Health goals to providers and social supports
Study NCT05400252 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health and Wellness
Description: Health \& Wellness is an educational wellness intervention
Study NCT06499688 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rcombinant botulinum neurotoxin type A for injection (YY001)
Description: Single treatment,intramuscularly injected into five sites.The total injection volume is 0.25 ml,0.05 ml per site.
Study NCT06499688 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: OnabotulinumtoxinA
Description: Single treatment,intramuscularly injected into five sites.The total injection volume is 0.25 ml,0.05 ml per site.
Study NCT06499688 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single treatment,intramuscularly injected into five sites.The total injection volume is 0.25 ml,0.05 ml per site.
Study NCT05603065 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab + cisplatin + paclitaxel
Description: Tislelizumab 200mgD1 + cisplatin 75mg/m\^2D1 + paclitaxel 150mg/m\^2D1 Q3W 3 cycles
Study NCT05603065 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab + radiotherapy
Description: Tislelizumab 200mgQ3W 3 cycles + radiotherapy (23 times in total, 1.8 Gy per dose, 5 times a week)
Study NCT05623371 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Training leaders in leading well-being and the psychosocial working environment
Description: The intervention comprises five training modules with practice in small groups in between. Training will take place over 5 months. The training will be received in groups of 20 and the training will be facilitated by 2 facilitators. Central themes of the training are:~1. Self-care and well-being of the manager and how to cope with stress as a manager.~2. Employee well-being and reducing risk-factors in the psychosocial working environment of employee mental health problems~3. Enhancing protective factors social social support and a healthy team climate~4. Responding to employees at risk and how to handle difficult conversations and procedures on return to work~5. Managing well-being in employees during organizational change and final reflections~The training will comprise video material and in person training of competencies and behaviors in group settings.~The waitlist control group will receive an offer of a webinar and written information.
Study NCT05623371 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The offer of a webinar and written material
Description: The offer of a webinar plus written material
Study NCT06325345 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy
Description: Eight session gut-directed hypnotherapy for IBS symptoms adapted from the evidence-based Manchester protocol for treatment of IBS.
Study NCT06325345 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard Medical Therapy
Description: Standard medical treatment will be administered by board certified gastroenterologists
Study NCT06325345 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Medical Therapy
Description: Standard medical treatment will be administered by board certified gastroenterologists
Study NCT05765747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yunnan Baiyao
Description: Yunnan Baiyao group will be given 4 times a day, 2 capsules each time after morning, afternoon and evening meals and before going to bed. One capsule of Baoxianzi will be provided for the first time to be taken at the same time with Yunnan Baiyao Capsule, which will be given continuously for 2 weeks.
Study NCT05765747 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Celecoxib 200mg
Description: The celecoxib group will be given 1 capsule twice a day after breakfast and dinner for 2 weeks.
Study NCT05020704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 MG
Description: SGLT2inhibitor
Study NCT05020704 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched placebo
Study NCT05207085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valbenazine Oral Capsule
Description: Participants randomized to active treatment will be given a starting dose of 40mg of valbenazine , which may be escalated to 80mg to achieve an optimal dose of the medication for each subject.
Study NCT05207085 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral capsule
Description: Participants randomized to placebo will be given a capsule that is the same shape and color as the active medication and will subject to the same dose escalation requirements as the other arm but will receive placebo during the treatment period.
Study NCT05889208 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Prophylactic pacemaker implantation
Description: Pacemaker implantation prior the TAVI-procedure
Study NCT06504524 — intervention group
Intervention type: DRUG
Intervention: Elranatamab
Description: BCMA-CD3 bispecific antibody
Study NCT06504524 — intervention group
Intervention type: DRUG
Intervention: Standard of Care
Description: control arm
Study NCT06432946 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video
Description: A 7-minute video demonstrating the sensing-glove system, how it can be used to assess manual therapy biomechanics, and its relevance in research and clinical contexts. The video was created by the research team via a voiceover PowerPoint presentation.
Study NCT06432946 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Practice session
Description: A 20-minute practice session during which participants received verbal information about the sensing-glove system. While wearing the sensing glove, participants performed palpation and manual therapy techniques (palpation, spinal mobilization/manipulation to the cervical and thoracic spine) on a human-sized manikin, guided by the researcher.
Study NCT05230199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SENSE multisensory program
Description: In order to support parent's ability to implement the daily SENSE program they will be provided with an educational manual reviewing the program, weekly meetings with a therapist, and logs to report their visitation schedule and activities. Parents are able to choose different types of each sensory exposure. All options address the same key principles for that behavior and only include those that have evidence to support their use and are appropriate at each PMA.
Study NCT05230199 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Monitored standard of care
Description: Infants who receive sensory exposures only as standard of care but do not recieve the SENSE program
Study NCT06141421 — intervention group
Intervention type: PROCEDURE
Intervention: procedure
Description: procedure
Study NCT05547776 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness app
Description: The mindfulness app contains 6 modules with a variety of features to help caregivers reduce their stress.
Study NCT05666817 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: breastfeeding education
Description: Mothers in the intervention group will be given breastfeeding training after the pre-test application. The content of breastfeeding education is as follows;~* General information about breastfeeding,~* General information about breast milk and the benefits of breast milk,~* Benefits of breastfeeding for mother and baby,~* How the baby should be held during breastfeeding, the baby's position,~* Effective breastfeeding positions for the mother,~* Ensuring that the baby holds the breast correctly,~* Providing the correct breastfeeding technique,~* Breast milking and storage conditions,~* The necessity and benefits of continuing breastfeeding.
Study NCT04908475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Risankizumab
Description: Subcutaneous injection
Study NCT04908475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apremilast
Description: Oral Tablets
Study NCT05628298 — intervention group
Intervention type: DEVICE
Intervention: Soovu Pain Relief System
Description: The Soovu Pain Relief system uses pulses of heat to block the TRPV-1 calcium channel on peripheral pain nerves. The study will determine if the FDA cleared device significantly reduces the subject's pregnancy related pain.
Study NCT04638803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRX-P4-003, (-)-FCF
Description: sequential study
Study NCT05739110 — intervention group
Intervention type: BEHAVIORAL
Intervention: tumor micronecrosis
Description: whether HCC patients have tumor micronecrosis or not
Study NCT04745936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Style curve similar to natural curvature of endotracheal tube
Description: Stylet curvature is made similar to the natural curvature of endotracheal tube for intubation using C-MAC videolaryngoscope.
Study NCT04745936 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Style curve similar to hockey stick shape
Description: Stylet curvature is made similar to hockey stick shape for intubation using C-MAC videolaryngoscope.
Study NCT05072262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nepafenac Ophthalmic
Description: Topical nepafenac (Nevanac) 3 mg/ml
Study NCT05072262 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone Ophthalmic
Description: Topical dexamethasone 1 mg/ml (Spersadex)
Study NCT05072262 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone Ophthalmic
Description: Topical dexamethasone 1 mg/ml (Spersadex)
Study NCT05964959 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mouth Educational Program
Description: The Mouth Educational Program is a nurse-led patient education program for dry mouth in patients with a life-limiting condition or frailty.
Study NCT05964959 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Care as Usual
Description: Care as usual is defined as the standard dry mouth care as provided by participants' own treating physicians.
Study NCT06229899 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Serum follistatin levels
Description: blood samples are taken
Study NCT05619770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 101-PGC-005
Description: Bolus Injection containing 30mg of 101-PGC-005 will administered intravenously once daily for 3 consecutive days
Study NCT05961982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chemical Ablation
Description: Undergo EUS-guided chemoablation
Study NCT05961982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05961982 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Health Record Review
Description: Ancillary studies
Study NCT05961982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Ultrasound-Guided Fine-Needle Aspiration
Description: Undergo EUS-FNA
Study NCT05961982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Ultrasound-Guided Radiofrequency Ablation
Description: Undergo EUS-RFA
Study NCT05961982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Cholangiopancreatography
Description: Undergo MRI/MRCP
Study NCT05961982 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI/MRCP
Study NCT05689281 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer PrEP Navigation
Description: Ecological momentary assessments to identify and address stressors related to social determinants of health (e.g., housing, substance use, mental health), and motivational interviewing to support participants' health care empowerment and progression along the PrEP continuum.
Study NCT05167032 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Multisensory Rehabilitation (CMR)
Description: The goal of CMR is to restore proprioception (i.e., sense of joint position and movement), body awareness, and awareness of the paralyzed limbs and trunk in space, in order to improve sensory and motor function. For example, CMR tasks will have the participant solve exercises related to: (i) where the legs are situated in space; where the legs are in relation to the pelvis and the upper part of the body (ii) the dimensions and length of the legs, the dimension of the pelvis, and sensation of the pelvis as a central body reference. (iii) the relationship between the left and right side of the body, and the relationship between the pelvis and the feet. Further, improvements in touch and pressure sensation are obtained with (v) texture discrimination tasks, and (vi) discrimination of sponges with varying resistance. Given the importance of sensory feedback for movement, sensory improvements create the opportunity for motor recovery to occur.
Study NCT05167032 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Adaptive fitness
Description: The Courage Kenny Rehabilitation Institute centers provide access to state-of- the-art adaptive gym equipment in their fitness center to promote fitness and recreation. Equipment includes treadmills, elliptical, NuSteps, SciFit upper body ergometers, Ski Erg and Rowing Machine, Upright and recumbent stationary bicycles, chest press, rear row, leg extension, leg curl, leg press, uppertone, free weights, and kettlebells. The equipment is spaced to allow for movement and is accessible for use from a wheelchair. They allow for transfers and caregiver assistance.
Study NCT05777941 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eccentric arm-cranking training
Description: Over the twenty training sessions, able-bodied participants will exercise on the KREHA device. An arm-crank has to be decelerated, which will be rotated by a prematurely defined revolution rate and training duration. During this intervention a certain power has to be applied. During the whole time of training a continous progression in power and training duration is applied.
Study NCT06197308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oral vancomycin and oral amoxicillin
Description: In this study, PSC patients will receive an antibiotic preconditioning regimen of oral vancomycin (500 mg liquid twice a day) for 28 days and oral amoxicillin (1000 mg twice a day) for 7 days (during the last 7 days of the oral vancomycin). Following vancomycin and amoxicillin, encapsulated, freeze-dried microbiota preparation (MTP-101C) will be administered - dosed at ≥ 5 x 10\^11 bacteria (five capsules) daily for 3 days followed by ≥ 2 x 10\^11 bacteria (two capsules) for 11 days - for a total of 14 days of MTP-101C; total of 37 capsules.
Study NCT03949465 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulator
Description: Repetitive Transcranial magnetic stimulation (rTMS) will be delivered using a MagPro X100 device with B70 coil and the intermittent theta burst (iTBS) protocol to the left dorsolateral prefrontal cortex. Participants will receive daily treatments (Monday-Friday) over four weeks
Study NCT05095311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetirizine HCl
Description: Eight participants will be administered 10 mg of cetirizine HCl to examine whether this drug can improve their oxyhemoglobin saturation during exercise.
Study NCT05095311 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: The placebo pill is a sugar-free gelatin pill casing. The placebo inhaler contains isotonic saline.
Study NCT06730269 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face-to-Face Rehabilitation Program
Description: The Face-to-Face Rehabilitation Program is a structured rehabilitation regimen designed to improve posture, reduce pain, and strengthen back extensor muscles in children with thoracic hyperkyphosis. Participants in this group engaged in the Thoracic Corrective Exercise Program, which included four specific exercises targeting thoracic spine correction. The exercises were performed three times per week over six weeks, under the direct supervision of a trained therapist. This setup ensured real-time feedback, personalized adjustments, and guidance during each session, optimizing the effectiveness of the rehabilitation process.
Study NCT05474898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Magnesium Sulphate Iontophoresis +conventional therapy
Description: will receive Mgso4 Iontophoresis in addition to conventional therapy twice a week/4 weeks
Study NCT05474898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High- Power Pain Threshold Ultrasound +conventional therapy
Description: will receive HPPT-US on the upper trapezius in addition to conventional therapy twice a week/4 weeks
Study NCT06730269 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telerehabilitation Program
Description: The Telerehabilitation Program is a structured rehabilitation regimen designed to improve posture, reduce pain, and strengthen back extensor muscles in children with thoracic hyperkyphosis. Participants in this group followed the Thoracic Corrective Exercise Program, which included four specific exercises targeting thoracic spine correction, performed three times per week over six weeks. The program was delivered remotely through the Fiziu platform, allowing therapists to provide virtual guidance, feedback, and monitoring during the sessions. This approach offered flexibility for families and ensured accessibility to rehabilitation services from the comfort of their homes.
Study NCT06730230 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Remote Patient Monitoring (RPM)-enabled Community Health Worker (CHW) Support
Description: CHWs will implement RPM by being provided with training modules and implementing electronic health record (EHR) support tools for HTN management.
Study NCT05249621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MZE001
Description: Small molecule inhibitor of muscle glycogen synthase
Study NCT05249621 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Product containing excipients with no active ingredients
Study NCT05474898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional theapy
Description: will receive postural correction exercise-stretching and strengthening twice a week/4weeks
Study NCT05741814 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Gynecologist guided individualised propofol only sedation
Study NCT05279768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UC-MSCs
Description: Treatment with tablet (placebo) once for 30 days, IV 0.3 million kg/bb UC-MSCs once, and nasal drop 0.5 ml/day (growth medium) for 30 days.
Study NCT05279768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Secretomes
Description: Treatment with tablet (placebo) once for 30 days, IV placebo (NaCl 0.9%) once, and nasal drop 0.5 ml/day (Secretomes) for 30 days.
Study NCT05279768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UC-MSCs and Secretomes
Description: Treatment with tablet (placebo) once for 30 days, IV 0.3 million kg/bb UC-MSCs once, and nasal drop 0.5 ml/day (Secretomes) for 30 days.
Study NCT05279768 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Treatment with Metformin once for 30 days, IV placebo (NaCl 0.9%) once, and nasal drop 0.5 ml/day (growth medium) for 30 days.
Study NCT05474898 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conventional theapy
Description: will receive postural correction exercise-stretching and strengthening twice a week/4weeks
Study NCT05112159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPG1094
Description: The IPG1094 drug product is supplied as oral tablet dosage form, containing two strengths: 50 mg and 100 mg, respectively, which contain IPG1094.
Study NCT05112159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo
Description: Matching placebo tablets to IPG1094 50mg and 100mg
Study NCT04889599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BH009 (Docetaxel injection)
Description: 75mg/m2
Study NCT04889599 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel injection
Description: 75mg/m2